key: cord-0832561-dmgn26wt authors: Bhatt, Ankeet S.; Vaduganathan, Muthiah title: Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients? date: 2020-11-24 journal: J Am Coll Cardiol DOI: 10.1016/j.jacc.2020.09.548 sha: 9d9153572ed63c6d1948886bde3ee1404dfa1902 doc_id: 832561 cord_uid: dmgn26wt nan We read with interest the paper by Moonsamy et al. (1) and its associated editorial (2). The authors reported a plant. An approach of longer-term temporary mechanical circulatory support (MCS) (e.g., Impella 5.0, Centrimag) to allow for end-organ recovery, followed by reassessment of suitability for advanced HF therapies, may provide more judicious use of invasive and expensive durable MCS or scarce organs. There is significant heterogeneity within ECMOsupported patients with prognostic implications. Thus, placing all ECMO-supported patients in a single group may not be appropriate. Further investigation is needed to risk-stratify these patients and to identify the best strategy to help patients who are critically ill and in need of advanced HF therapies. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 Pandemic